Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 15/20 | 0.64 |
| ▸ | DRD2 | P14416 | 14/20 | 0.64 |
| ▸ | HTR7 | P34969 | 5/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.64 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.64 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.64 |
| ▸ | DRD1 | P21728 | 2/20 | 0.64 |
| ▸ | DRD4 | P21917 | 2/20 | 0.64 |
| ▸ | DRD5 | P21918 | 2/20 | 0.64 |
| ▸ | HTR1D | P28221 | 2/20 | 0.64 |
| ▸ | HTR1B | P28222 | 2/20 | 0.64 |
| ▸ | HTR2C | P28335 | 2/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.64 |
| ▸ | HRH1 | P35367 | 2/20 | 0.64 |
| ▸ | DRD3 | P35462 | 2/20 | 0.64 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.64 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.57 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12414760 | 0.97 | HTR2A (0.67) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12414761 | 0.94 | HTR2A (0.73) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12414767 | 0.90 | DRD2 (0.68) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12414762 | 0.88 | HTR2A (0.73) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12415622 | 0.88 | HTR2A (0.66) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12414764 | 0.88 | HTR2A (0.69) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12415662 | 0.88 | HTR2A (0.72) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12415616 | 0.88 | DRD2 (0.74) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12415620 | 0.86 | HTR2A (0.71) | HTR2ADRD2HTR7KCNH2ADRA2A | |
| SCHEMBL12415665 | 0.85 | DRD2 (0.69) | HTR2ADRD2HTR7KCNH2ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166156-A1 | Prodrugs for the Treatment of Schizophrenia and Bipolar Disease | ALKERMES, INC. (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166156-A1 | Prodrugs for the Treatment of Schizophrenia and Bipolar Disease | SLC1A2, BDNF, MAOB | HTR2A 703/4885DRD2 581/4885HTR7 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.